Aligos Therapeutics, Inc. research brief

CIK 1799448 Copy CIK

Generated Nov. 13, 2026, 1:50 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: South San Francisco California. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

• Feb. 28, 2025 · D · 0000950123-25-002925 · Source evidence

  Reported offering amount: 105003206 USD. Reported amount sold: 105003206 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Aligos Therapeutics, Inc. research brief,” CIK 1799448, retrieved Nov. 13, 2026, 1:50 p.m.. Cite the specific accessions used. No amounts have been summed.